The [GMP Interleukin Market] is experiencing sustained growth, fundamentally driven by the critical need for regulatory-compliant, high-quality ancillary materials in the manufacturing of advanced therapies. As cell and gene therapies move from the lab to the clinic, the demand for GMP-certified cytokines, which meet stringent standards set by bodies like the FDA and EMA, has...